Company News 

Clinigen expanding with Quantum acquisition

Clinigen expanding with Quantum acquisition

When Shaun Chilton applied for the top job at specialist pharmaceutical group Clinigen (CLIN) last year, he set out a list of companies and drugs he hoped to bring into the group’s portfolio. Already he has got his hands on one of those targets. Quantum Pharma’s (QP.) directors have agreed to a £150m takeover, which is expected to complete in early November – providing 75 per cent of the target’s shareholders agree to the offer. Mr Chilton has chosen to fund this acquisition via a cash and equity transaction, “to leave headroom for other things”.

To continue reading, subscribe today

and enjoy unlimited access to the following:

  • Tips of the Week
  • Funds coverage
  • Weekly features on big investment themes
  • Trading ideas
  • Comprehensive companies coverage
  • Economic analysis
Subscribe
Subscribe to Investors Chronicle

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now